Incidence and characterization of acute pulmonary embolism in patients with SARS-CoV-2 pneumonia: A multicenter Italian experience.
Journal
PloS one
ISSN: 1932-6203
Titre abrégé: PLoS One
Pays: United States
ID NLM: 101285081
Informations de publication
Date de publication:
2021
2021
Historique:
received:
28
10
2020
accepted:
04
01
2021
entrez:
22
1
2021
pubmed:
23
1
2021
medline:
3
2
2021
Statut:
epublish
Résumé
Several studies reported a high incidence of pulmonary embolism (PE) among patients with severe acute respiratory syndrome coronavirus-2 (SARS-CoV-2) infection, but detailed data about clinical characteristics, risk factors of these patients and prognostic role of PE are still lacking. We aim to evaluate the occurrence of pulmonary embolism among patients with SARS-CoV-2 infection, and to describe their risk factors, clinical characteristics, and in-hospital clinical outcomes. This is a multicenter Italian study including 333 consecutive SARS-CoV-2 patients admitted to seven hospitals from February 22 to May 15, 2020. All the patients underwent computed tomography pulmonary angiography (CTPA) for PE detection. In particular, CTPA was performed in case of inadequate response to high-flow oxygen therapy (Fi02≥0.4 to maintain Sp02≥92%), elevated D-dimer (>0.5μg/mL), or echocardiographic signs of right ventricular dysfunction. Clinical, laboratory and radiological data were also analyzed. Among 333 patients with laboratory confirmed SARS-CoV-2 pneumonia and undergoing CTPA, PE was detected in 109 (33%) cases. At CTPA, subsegmental, segmental, lobar and central thrombi were detected in 31 (29%), 50 (46%), 20 (18%) and 8 (7%) cases, respectively. In-hospital death occurred in 29 (27%) patients in the PE-group and in 47 (21%) patients in the non-PE group (p = 0.25). Patients in PE-group had a low rate of traditional risk factors and deep vein thrombosis was detected in 29% of patients undergoing compression ultrasonography. In 71% of cases with documented PE, the thrombotic lesions were located in the correspondence of parenchymal consolidation areas. Despite a low rate of risk factors for venous thromboembolism, PE is present in about 1 out 3 patients with SARS-CoV-2 pneumonia undergoing CTPA for inadequate response to oxygen therapy, elevated D-dimer level, or echocardiographic signs of right ventricular dysfunction. In most of the cases, the thromboses were located distally in the pulmonary tree and were mainly confined within pneumonia areas.
Sections du résumé
BACKGROUND AND AIMS
Several studies reported a high incidence of pulmonary embolism (PE) among patients with severe acute respiratory syndrome coronavirus-2 (SARS-CoV-2) infection, but detailed data about clinical characteristics, risk factors of these patients and prognostic role of PE are still lacking. We aim to evaluate the occurrence of pulmonary embolism among patients with SARS-CoV-2 infection, and to describe their risk factors, clinical characteristics, and in-hospital clinical outcomes.
METHODS
This is a multicenter Italian study including 333 consecutive SARS-CoV-2 patients admitted to seven hospitals from February 22 to May 15, 2020. All the patients underwent computed tomography pulmonary angiography (CTPA) for PE detection. In particular, CTPA was performed in case of inadequate response to high-flow oxygen therapy (Fi02≥0.4 to maintain Sp02≥92%), elevated D-dimer (>0.5μg/mL), or echocardiographic signs of right ventricular dysfunction. Clinical, laboratory and radiological data were also analyzed.
RESULTS
Among 333 patients with laboratory confirmed SARS-CoV-2 pneumonia and undergoing CTPA, PE was detected in 109 (33%) cases. At CTPA, subsegmental, segmental, lobar and central thrombi were detected in 31 (29%), 50 (46%), 20 (18%) and 8 (7%) cases, respectively. In-hospital death occurred in 29 (27%) patients in the PE-group and in 47 (21%) patients in the non-PE group (p = 0.25). Patients in PE-group had a low rate of traditional risk factors and deep vein thrombosis was detected in 29% of patients undergoing compression ultrasonography. In 71% of cases with documented PE, the thrombotic lesions were located in the correspondence of parenchymal consolidation areas.
CONCLUSIONS
Despite a low rate of risk factors for venous thromboembolism, PE is present in about 1 out 3 patients with SARS-CoV-2 pneumonia undergoing CTPA for inadequate response to oxygen therapy, elevated D-dimer level, or echocardiographic signs of right ventricular dysfunction. In most of the cases, the thromboses were located distally in the pulmonary tree and were mainly confined within pneumonia areas.
Identifiants
pubmed: 33481902
doi: 10.1371/journal.pone.0245565
pii: PONE-D-20-33946
pmc: PMC7822531
doi:
Substances chimiques
Fibrin Fibrinogen Degradation Products
0
fibrin fragment D
0
Types de publication
Journal Article
Multicenter Study
Langues
eng
Sous-ensembles de citation
IM
Pagination
e0245565Déclaration de conflit d'intérêts
The authors also have declared that no competing interests exist.
Références
J Thromb Haemost. 2011 Oct;9(10):2115-7
pubmed: 21848693
J Thromb Haemost. 2020 May;18(5):1020-1022
pubmed: 32239799
Eur Heart J. 2020 Jul 1;41(32):3058-3068
pubmed: 32656565
Eur Heart J. 2020 May 14;41(19):1858
pubmed: 32227120
J Thromb Haemost. 2020 Apr;18(4):844-847
pubmed: 32073213
Int J Epidemiol. 2011 Jun;40(3):819-27
pubmed: 21324940
J Am Coll Cardiol. 2020 May 12;75(18):2352-2371
pubmed: 32201335
Thromb Res. 2020 Nov;195:95-99
pubmed: 32682004
Thromb Res. 2020 Jul;191:9-14
pubmed: 32353746
Clin Res Cardiol. 2021 Jul;110(7):1020-1028
pubmed: 33141251
J Thromb Haemost. 2020 Aug;18(8):1995-2002
pubmed: 32369666
Clin Appl Thromb Hemost. 2011 Feb;17(1):80-7
pubmed: 19689998
Lancet. 2020 Feb 15;395(10223):497-506
pubmed: 31986264
Semin Thromb Hemost. 2008 Jul;34(5):459-68
pubmed: 18956286
Lancet. 1996 May 18;347(9012):1357-61
pubmed: 8637340
Adv Pharmacol Sci. 2015;2015:507151
pubmed: 26064103
Ann Intern Med. 2020 Aug 18;173(4):268-277
pubmed: 32374815
J Thromb Haemost. 2020 Jul;18(7):1559-1561
pubmed: 32302453
Eur Heart J. 2020 Jul 1;41(32):3069-3071
pubmed: 32656564
Thromb Haemost. 2000 Aug;84(2):319-24
pubmed: 10959707
Am J Hematol. 2020 Jun;95(6):E131-E134
pubmed: 32129508
Tuberc Respir Dis (Seoul). 2020 Apr;83(2):157-166
pubmed: 32185917
Eur Respir J. 2019 Oct 9;54(3):
pubmed: 31473594
Thromb Res. 2020 Jul;191:145-147
pubmed: 32291094
Blood. 2007 Jun 15;109(12):5251-9
pubmed: 17332247
J Am Coll Cardiol. 2020 Jun 16;75(23):2950-2973
pubmed: 32311448
Radiology. 2020 Aug;296(2):E55-E64
pubmed: 32191587
Lancet. 2020 Feb 15;395(10223):507-513
pubmed: 32007143
Circulation. 2020 Jul 14;142(2):184-186
pubmed: 32330083
J Thromb Thrombolysis. 2016 Apr;41(3):404-12
pubmed: 26121973